Bamforth S D, Lightman S L, Greenwood J
Department of Clinical Ophthalmology, University College London, United Kingdom.
Am J Pathol. 1997 Jan;150(1):329-40.
The vascular barriers of the central nervous system form a selective cellular interface between the blood and the neural parenchyma and restrict the transfer of both molecules and hematogenous cells. During immune-mediated diseases, leukocyte infiltration becomes dramatically up-regulated and the permeability of these barriers increases, leading to edema formation. The etiology of this damage remains largely unresolved although inflammatory cytokines have been implicated in the process. The effect of the proinflammatory cytokine interleukin (IL)-1 beta on the integrity of the rat blood-retinal barrier (BRB) was investigated up to 14 days after an intravitreal injection. The permeability of the BRB was evaluated quantitatively using the low molecular weight tracer [14C]mannitol. After IL-1 beta administration, a biphasic opening of the BRB to [14C]mannitol was recorded, peaking at 4 to 8 hours and 24 to 48 hours post-injection (PI). The early disruption coincided with the appearance of both polymorphonuclear and mononuclear leukocytes within the retina. By 12 hours PI, BRB permeability had returned to control values despite a continued increase in the number of infiltrating leukocytes. The second, more pronounced increase in barrier permeability detected at 24 to 48 hours PI corresponded with maximal leukocyte infiltration. Barrier dysfunction had resolved by 72 hours, and by 7 days the leukocyte infiltrate had disappeared. The IL-1 beta-induced increase in permeability could be completely abrogated at 4 and 24 hours PI by treating the animals with the histamine H2-receptor antagonist ranitidine, which also reduced leukocyte infiltration by 47.2%. The ability of histamine to disrupt the BRB was demonstrated by intravitreal and intravascular administration, which caused a rapid and significant increase in BRB permeability. Treatment of the animals with the cyclo-oxygenase inhibitor indomethacin had no effect on IL-1 beta-induced disruption of the BRB at 4 hours PI, but by 24 hours PI a significant reduction in permeability was observed that coincided with a 75.2% reduction in the leukocyte infiltrate. The depletion of circulating leukocytes to < 2% of control levels reduced the retinal leukocyte recruitment induced by IL-1 beta by 73.0% and decreased BRB permeability at both 4 and 24 hours after IL-1 beta injection. These data demonstrate that intravitreal IL-1 beta in the rat induces a biphasic opening of the BRB that appears to be mediated through recruited leukocytes and release of the vasoactive amine histamine.
中枢神经系统的血管屏障在血液与神经实质之间形成了一个选择性细胞界面,限制了分子和造血细胞的转运。在免疫介导的疾病中,白细胞浸润显著上调,这些屏障的通透性增加,导致水肿形成。尽管炎症细胞因子参与了这一过程,但这种损伤的病因在很大程度上仍未得到解决。研究了玻璃体内注射促炎细胞因子白细胞介素(IL)-1β后长达14天对大鼠血视网膜屏障(BRB)完整性的影响。使用低分子量示踪剂[14C]甘露醇定量评估BRB的通透性。给予IL-1β后,记录到BRB对[14C]甘露醇的双相开放,在注射后(PI)4至8小时和24至48小时达到峰值。早期破坏与视网膜内多形核白细胞和单核白细胞的出现同时发生。到PI 12小时时,尽管浸润白细胞数量持续增加,但BRB通透性已恢复到对照值。在PI 24至48小时检测到的屏障通透性第二次更明显的增加与最大白细胞浸润相对应。屏障功能障碍在72小时时已消退,到7天时白细胞浸润已消失。在PI 4小时和24小时时,用组胺H2受体拮抗剂雷尼替丁治疗动物可完全消除IL-1β诱导的通透性增加,雷尼替丁还使白细胞浸润减少了47.2%。玻璃体内和血管内给药证明了组胺破坏BRB的能力,这导致BRB通透性迅速且显著增加。在PI 4小时时,用环氧化酶抑制剂吲哚美辛治疗动物对IL-1β诱导的BRB破坏没有影响,但到PI 24小时时,观察到通透性显著降低,这与白细胞浸润减少75.2%同时发生。将循环白细胞减少到对照水平的<2%可使IL-1β诱导的视网膜白细胞募集减少73.0%,并在IL-1β注射后4小时和24小时降低BRB通透性。这些数据表明,大鼠玻璃体内注射IL-1β会诱导BRB双相开放,这似乎是通过募集的白细胞和血管活性胺组胺的释放介导的。